—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Hims Hers Health Inc (HIMS) — the peer cohort

As of 2026-10-24 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Hims Hers Health Inc ranks 7 of 7 in its cohort on the Closelooknet composite (37/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 62/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
HIMS Hims Hers Health Inc 37 40 32 21 info 45.7%
ROVI.MC Laboratorios Farmaceuticos ROVI 62 32 77 51 info 29.4%
LNTH Lantheus Holdings Inc 60 68 73 56 info 10.8%
BHC.TO Bausch Health Companies Inc 57 76 71 83 info 18.5%
GALDY GALDERMA GROUP AG 57 73 59 26 info 0.2%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 56 92 58 47 ok 3.8%
IRWD Ironwood Pharmaceuticals Inc 56 33 77 83 info 40.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-24

Quick answers

Who are Hims Hers Health Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Bausch Health Companies Inc (BHC.TO), GALDERMA GROUP AG (GALDY), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Ironwood Pharmaceuticals Inc (IRWD).

How does HIMS score against its peers?

Hims Hers Health Inc's composite reads 37/100, ranking 7 of 7 in its cohort as of 2026-10-24; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 62/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.